These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4976154)

  • 21. Response of normal and multiple sclerotic subjects to typhoid-paratyphoid vaccine injections.
    FIELD EJ; GREEN CA; MILLER H
    J Neurol Neurosurg Psychiatry; 1961 Feb; 24(1):78-9. PubMed ID: 13699347
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of typhoid and paratyphoid with chloramphenicol and vaccine].
    Mariani I
    Med Glas; 1966 Oct; 20(10):383-5. PubMed ID: 4962658
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of foreign antigen (typhoid-paratyphoid-vaccine) upon BCG-infection in guinea pigs.
    WAALER E
    Acta Pathol Microbiol Scand; 1956; 38(6):466-80. PubMed ID: 13339338
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on the epidemiological effectiveness of corpuscular and chemically sorbed typho-paratyphoid vaccines].
    KHEIFETS LB
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Jul; 33():53-9. PubMed ID: 14455611
    [No Abstract]   [Full Text] [Related]  

  • 25. [A new method of intradermal antitypho-paratyphoid vaccination in a single dose].
    ARGUDIN GARCIA A
    Rev Cubana Pediatr; 1961; 33():171-84. PubMed ID: 13862211
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of typhoid and paratyphoid carriers].
    Yasuhara M
    Nihon Densenbyo Gakkai Zasshi; 1967 Sep; 41(6):197-206. PubMed ID: 4966964
    [No Abstract]   [Full Text] [Related]  

  • 27. [Material on the characteristics of the active immunity test in the evaluation of the immunogenicity of typhoid-paratyphoid vaccines in experiments on white mice].
    Rumiantsev SN; Karpenkova NI; Chalenko VG
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):9-15. PubMed ID: 4623777
    [No Abstract]   [Full Text] [Related]  

  • 28. [Advances in the preparation of combined vaccine against abdominal typhus, paratyphoid and tetanus (TABTe vaccine)].
    LA ROCCA V; BENZONI G
    Boll Ist Sieroter Milan; 1961; 40():18-29. PubMed ID: 13757935
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody and agglutinin response to TAB vaccination.
    HU HY; TSENG CS; HSU CN; YING KS
    Chin Med J; 1960 Jun; 80():554-61. PubMed ID: 14403630
    [No Abstract]   [Full Text] [Related]  

  • 30. [Reactivity and immunological and epidemiological effectiveness of alcoholic typho-paratyphoid vaccines in school children].
    KOVALEVSKAIA IL; GOLUOVA EE; GONCHAROVA ZI; SARMANEEV AP; SIZINTSEVA VP
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Jul; 33():72-7. PubMed ID: 14458980
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunological changes in children vaccinated with a dry alcoholic typho-paratyphoid divaccine].
    KOVALENSKAIA IL; KURNOSOVA NA; SHCHEGLOVA ES; SHIPOVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Jan; 33():46-50. PubMed ID: 14458960
    [No Abstract]   [Full Text] [Related]  

  • 32. The formation of macroglobulin antibodies. I. Studies on adult humans.
    LOSPALLUTO J; MILLER W; DORWARD B; FINK CW
    J Clin Invest; 1962 Jul; 41(7):1415-21. PubMed ID: 14466770
    [No Abstract]   [Full Text] [Related]  

  • 33. Typhoid and paratyphoid fever.
    Basnyat B
    Lancet; 2005 Nov; 366(9497):1603. PubMed ID: 16271636
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of antibiotic therapy on the development of chronic carrier state in abdominal typhus].
    Ferdinand IaM; Redechkina ZP; Vozzhaeva AP; Vetlungina KF; Veviur NA; Zhiguliskaia IF; Borozdenko TF
    Antibiotiki; 1966 Sep; 11(9):840-3. PubMed ID: 4968210
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on epidemiological efficiency of the IEM Gamaleya vaccine with special reference to typhoid and paratyphoid B fevers].
    SEMINA NA
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Jul; 30():7-10. PubMed ID: 14444833
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunologic basis for typhoid carrier state formation and methods of prevention].
    Bunin KV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):5-10. PubMed ID: 5519106
    [No Abstract]   [Full Text] [Related]  

  • 37. [TYPHOID AND PARATYPHOID CARRIERS. I. METHODS OF DETECTION AND CONTROL OF TYPHOID AND PARATYPHOID CARRIERS. (REVIEW OF THE FOREIGN LITERATURE)].
    OLKOVA MP; SOLODOVNIKOV IuP
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jun; 41():53-6. PubMed ID: 14232049
    [No Abstract]   [Full Text] [Related]  

  • 38. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Animal experiments on antibody formation following thymectomy in adult rabbits].
    Hempel HC; Grimm J; Schwarz ER; Hofmann K; Korn D
    Dtsch Gesundheitsw; 1969 Jul; 24(28):1304-7. PubMed ID: 4987620
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of development of the bacterial carrier state through vaccine-antibiotic therapy of patients with typhoid and paratyphoid. 1. Pecularities of the course of thyphoid and paratyphoid in the complex therapy of patients with levomycetin and dry alcoholic typhoid-paratyphoid B divaccine].
    Bilibin AF; Musabaev IK; Medvedev AS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):107-12. PubMed ID: 4965909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.